---
title: Migraine Guidelines 2026 UK | Updated SIGN Migraine Treatment Advice
description: Discover the updated SIGN migraine guidelines for 2026, including new recommendations on migraine treatment, prevention, medication use, and holistic migraine management in the UK.
---

<https://blog.tribelle.co.uk>

# [Migraine Guidelines 2026 UK | Updated SIGN Migraine Treatment Advice](https://blog.tribelle.co.uk/sign-migraine-guidelines-2026-uk)

 Written by [TribElle Clinical Team](https://blog.tribelle.co.uk/author/tribelleclinicalteam) | 9 Jun 2026, 11:02:42

Reviewed by **Julie Boora**, Superintendent Pharmacist, TribElle Health Ltd (GPhC Reg. 9012688)

| 10M+ UK migraine sufferers |  | #3 Most disabling condition worldwide |  | 2026 Updated SIGN guidance |
| --- | --- | --- | --- | --- |

 

Migraines affect more than 10 million people across the UK and remain one of the most common neurological conditions worldwide. For many individuals, migraine attacks can significantly impact work, sleep, mental wellbeing, family life, and overall quality of life.

The updated SIGN migraine guidance for 2026 introduces important recommendations designed to improve migraine diagnosis, treatment, prevention, and long-term management.

The latest guidance reflects a growing understanding that migraine is not "just a headache" — it is a complex neurological condition requiring personalised, evidence-based care.

Quick answer

The primary goal of the new SIGN migraine guidance is to improve migraine outcomes through **earlier diagnosis, evidence-based treatment, preventative care, and better long-term management strategies.**

 

## What are the updated SIGN migraine guidelines?

The Scottish Intercollegiate Guidelines Network (SIGN) updated its migraine recommendations to reflect the latest clinical evidence surrounding:

Acute treatment Preventative therapies Medication overuse Lifestyle management Patient education Personalised care planning

 

## Understanding migraine: more than a headache

Migraine is a neurological condition that can cause a wide range of symptoms. Attacks may last from several hours to multiple days and vary significantly between individuals.

| Common symptoms →Severe throbbing head pain →Sensitivity to light and sound →Nausea and vomiting →Visual disturbances or aura | Also common →Fatigue →Dizziness →Cognitive difficulties →Brain fog |
| --- | --- |

The updated SIGN guidance reinforces the importance of recognising migraine as a serious health condition that often requires ongoing management rather than occasional symptom treatment.

 

## Key changes in the 2026 migraine guidance

The updated recommendations place greater emphasis on three areas:

| 1 | Early and accurate diagnosis Many migraine sufferers experience delayed diagnosis or confusion with other headache disorders. The guidance encourages clinicians to improve diagnostic accuracy by identifying common migraine patterns, triggers, and associated neurological symptoms earlier. |
| --- | --- |

| 2 | Preventative migraine treatment Preventative therapies are increasingly recommended for people experiencing frequent or disabling migraine attacks. The guidance highlights the importance of considering preventative treatment when migraines significantly affect: → Daily function, employment, and education → Sleep and mental wellbeing |
| --- | --- |

| 3 | Avoiding medication overuse headaches Frequent use of painkillers can sometimes worsen headaches over time. The updated recommendations stress the importance of reviewing medication use carefully to reduce the risk of medication overuse headaches, which can become difficult to manage long term. |
| --- | --- |

 

## Recommended migraine treatments in 2026

The SIGN update supports a combination of medical and non-medical migraine management approaches.

| Acute treatments For immediate symptom relief, clinicians may consider: →Triptans →Anti-inflammatory medications →Antiemetics for nausea →Combination therapies where appropriate | Preventative treatment Preventative medication may help reduce: →Migraine frequency →Attack severity and duration →Reliance on acute medication |
| --- | --- |

 

## Lifestyle and trigger management

The guidance also highlights the importance of identifying and managing common migraine triggers:

😰 Stress 😴 Sleep disruption 💊 Hormonal changes 💧 Dehydration 🍷 Certain foods or alcohol 📱 Excessive screen exposure

Keeping a **migraine diary** may help you identify patterns and improve self-management — and is something many clinicians now recommend as part of a personalised care plan.

 

## The importance of holistic migraine care

One of the most important themes in the updated guidance is the move toward holistic, patient-centred care. Migraine is closely linked with broader health factors:

| 🧠 Mental wellbeingAnxiety and stress are both triggers and consequences of chronic migraine | 😴 Sleep qualityPoor sleep increases attack frequency and severity |
| --- | --- |
| 💊 Hormonal healthHormonal changes are a significant migraine trigger in women | 🥗 Diet and hydrationDehydration and dietary triggers are among the most common and manageable factors |

 

## Common symptoms you should not ignore

The updated guidance encourages patients to seek professional support if they experience:

Seek professional support if you notice:

| ⚠ Frequent migraine attacks | ⚠ Worsening headache severity |
| --- | --- |
| ⚠ Neurological symptoms | ⚠ Sudden changes in headache patterns |
| ⚠ Significant impact on daily life | ⚠ Medication becoming less effective |

 

## How TribElle supports modern migraine management

As migraine care evolves, TribElle supports a modern approach that reflects the latest guidance:

| 🎯 Patient-centred wellbeingPersonalised care that treats the whole person, not just the headache | 📋 Evidence-informed careTreatments aligned with the latest SIGN guidance and clinical evidence |
| --- | --- |
| 🔄 Long-term managementSupport strategies focused on reducing frequency and severity over time | 📚 Education and self-managementHelping you understand your triggers and take control of your care |

 

## Where Can You Get Migraine Treatment in the UK?

If you've been diagnosed with migraine, there are several ways to access treatment depending on the severity and frequency of your symptoms.

For **occasional migraines**, many UK online pharmacies, including **TribElle**, can assess your suitability for acute prescription treatments such as triptans following an online consultation with a UK-registered prescriber.

However, if you're experiencing frequent or disabling migraines, you may benefit from assessment by a specialist headache clinic or neurologist.

### What Is Chronic Migraine?

According to UK clinical guidance, **chronic migraine** is defined as experiencing:

- **15 or more headache days each month**, and
- **At least 8 of those days have migraine features**

People living with chronic migraine often require preventive treatment rather than medication taken only during an attack. Specialist assessment can help determine which treatment options may be most appropriate.

## Treatments Available for Chronic Migraine

If your migraines occur frequently or significantly affect your quality of life, a specialist may recommend preventive treatment to reduce the number and severity of migraine attacks.

Depending on your medical history and previous treatments, options may include:

### Oral Preventive Medicines

Common first-line preventive medicines include:

- Propranolol
- Candesartan
- Topiramate
- Amitriptyline

These medicines are taken regularly to help reduce migraine frequency rather than treating an individual attack.

### Botulinum Toxin (Botox®)

Botulinum toxin may be recommended for adults with chronic migraine who have not responded to, or cannot tolerate, at least three preventive medicines. Treatment is administered by trained specialists and is usually repeated approximately every 12 weeks.

### CGRP-Targeted Treatments

Calcitonin Gene-Related Peptide (CGRP) therapies have transformed migraine prevention for many people living with chronic migraine.

Depending on clinical eligibility, these treatments may include:

- Erenumab
- Fremanezumab
- Galcanezumab
- Eptinezumab

These medicines work by blocking the CGRP pathway involved in migraine attacks and are typically prescribed by specialist headache services.

### Atogepant

Atogepant is an oral CGRP receptor antagonist used for migraine prevention in eligible patients and may be prescribed in accordance with current NICE guidance.

## NHS or Private Migraine Treatment?

### NHS Care

People who meet NICE eligibility criteria may be referred by their GP to a neurologist or specialist headache clinic for advanced migraine treatments such as Botox® or CGRP-targeted medicines.

Waiting times vary across the UK depending on local services.

### Private Care

Private headache clinics and consultant neurologists may offer earlier access to specialist assessment and advanced migraine treatments where clinically appropriate.

Private treatment may be suitable for people seeking faster access to specialist advice or those wishing to explore additional treatment options.

## How TribElle Can Help

TribElle is a **UK-registered online pharmacy specialising in women's health**. While we do not currently provide specialist chronic migraine management, we support women experiencing **episodic migraine** by offering convenient online consultations for suitable acute migraine treatments, alongside trusted clinical advice and educational resources.

If your migraine symptoms are becoming more frequent, your medication is no longer effective, or you're experiencing headaches on 15 or more days each month, we recommend speaking to your GP or requesting referral to a specialist headache service for further assessment.

### References

1. National Migraine Centre. *Migraine treatment and specialist services.*
2. NICE. *Headaches in over 12s: diagnosis and management (CG150).*
3. International Headache Society. *International Classification of Headache Disorders, 3rd edition (ICHD-3).*
4. NICE Technology Appraisal: Botulinum toxin type A for the prevention of headaches in adults with chronic migraine.
5. NICE Technology Appraisal: Atogepant for preventing episodic migraine.
6. NICE. *Headaches in over 12s: diagnosis and management (CG150).*
7. British Association for the Study of Headache (BASH). *National migraine management guidance.*

## Frequently asked questions

What causes migraines? +

Migraines are believed to involve complex neurological, genetic, hormonal, and environmental factors. Triggers vary between individuals and can include stress, sleep disruption, hormonal changes, dehydration, certain foods, and excessive screen use.

Are migraines hereditary? +

Yes. Many people with migraines have a family history of the condition, suggesting a strong genetic component. However, environmental and lifestyle factors also play a significant role in how often and how severely migraines occur.

What is a migraine aura? +

Aura refers to neurological symptoms that may occur before or during a migraine attack, such as visual disturbances, numbness, tingling, or speech difficulties. Not all people with migraines experience aura.

When should preventative migraine treatment be considered? +

Preventative treatment may be recommended if migraines occur frequently, significantly affect daily life, work, sleep, or mental wellbeing, or if acute medication is becoming less effective. The updated SIGN guidance encourages earlier consideration of preventative options rather than waiting until migraines become severely disabling.

Can lifestyle changes help migraines? +

Yes. Improving sleep, hydration, stress management, and trigger awareness can help reduce migraine frequency and severity. The updated SIGN guidance places significant emphasis on lifestyle management as part of a holistic, long-term migraine care plan.

 

Bottom line

The updated SIGN migraine guidelines for 2026 represent an important step forward in improving migraine care across the UK. By focusing on earlier diagnosis, preventative treatment, safer medication use, and holistic support, the guidance encourages a more effective and compassionate approach to migraine management.

For patients living with migraines, this means greater recognition of the condition's impact and more personalised support strategies designed to improve long-term quality of life.

Managing migraines starts with having the right products to hand. Here's what we stock at TribElle.

### Ready to support your migraine management?

| [Nurofen 200mg Caplets £2.77](https://tribelle.co.uk/product-details/Nurofen%20200mg%20Caplets%20(16)) |
| --- |
| [4Head Migraine QuickStrips £5.00](https://tribelle.co.uk/product-details/4Head%20Headache%20Migraine%20QuickStrips%20(4)) |

© TribElle Health Ltd · GPhC Registration 9012688 · tribelle.co.uk · This content is for informational purposes only. Always consult a qualified healthcare professional.

🧠

Explore treatments

### Explore treatment types that might suit you

Hormone-aware migraine care and prescription options, reviewed by clinicians.

[See migraine treatments →](https://tribelle.co.uk/treatments/migraines)

[Or browse all TribElle treatments →](https://tribelle.co.uk/treatments)

Join the conversation

### You don't have to go through this alone

| 👥 Hormonal Migraine Support UK A community for women navigating hormone-related migraines Join group |
| --- |
| 💛 TribElle Weight Management Support Connect with other women on their weight management journey Join group |

[View full post](https://blog.tribelle.co.uk/sign-migraine-guidelines-2026-uk)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "TribElle Clinical Team"
  },
  "dateModified" : "2026-08-13T17:28:23.655Z",
  "datePublished" : "2026-06-09T11:02:42Z",
  "headline" : "Migraine Guidelines 2026 UK | Updated SIGN Migraine Treatment Advice",
  "image" : {
    "@type" : "ImageObject",
    "height" : 800,
    "url" : "https://48505236.fs1.hubspotusercontent-na1.net/hubfs/48505236/Home%20Testing%20Blog%20%283%29-2.png",
    "width" : 1600
  },
  "mainEntityOfPage" : "https://blog.tribelle.co.uk/sign-migraine-guidelines-2026-uk",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://48505236.fs1.hubspotusercontent-na1.net/hubfs/48505236/Logo.png",
      "width" : 140.99495
    },
    "name" : "TribeReads"
  }
}
```